Reduction of Stroke Incidence After Myocardial Infarction With Pravastatin
- 19 January 1999
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 99 (2), 216-223
- https://doi.org/10.1161/01.cir.99.2.216
Abstract
Background—The role of lipid modification in stroke prevention is controversial, although increasing evidence suggests that HMG-CoA reductase inhibition may reduce cerebrovascular events in patient...Keywords
This publication has 30 references indexed in Scilit:
- Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)The American Journal of Cardiology, 1995
- Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen city heart studyBMJ, 1994
- Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factorsThe American Journal of Cardiology, 1993
- Mechanism of late stroke after myocardial infarct: the Lausanne Stroke Registry.Journal of Neurology, Neurosurgery & Psychiatry, 1993
- Lipids Are Risk Factors for Ischaemic Stroke: Overview and ReviewCerebrovascular Diseases, 1992
- Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction: The cholesterol and recurrent events trial (CARE)The American Journal of Cardiology, 1991
- Twenty-Year Stroke Mortality and Prediction in Twelve Cohorts of the Seven Countries StudyInternational Journal of Epidemiology, 1990
- Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention TrialNew England Journal of Medicine, 1989
- A Controlled Clinical Trial of a Diet High in Unsaturated Fat in Preventing Complications of AtherosclerosisCirculation, 1969
- Relationship Between Arterial Disease in Different SitesBMJ, 1962